Findings presented at the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit in Montreal in April indicate that GLP-1 medications containing tirzepatide (Mounjaro and Zepbound) may help lower the risk of heart problems in people with obesity undergoing certain heart procedures
Important Note: Pregnant individuals should avoid taking any weight loss drugs, including fat blockers or appetite suppressants
Personalized Protocol Dr
Good sources include garlic, onions, leeks, asparagus, Jerusalem artichokes, chicory root, and slightly underripe bananas
This has contributed to the growing popularity of GHK-CU within cosmetic science, anti-aging research, and skin regeneration studies
RA already raises cardiovascular risk, and GLP-1 medications are proven to reduce cardiovascular events in obesity and diabetes, with improved risk profiles seen in the RA study.